Pharmacometric Characterization of Dabigatran Hemodialysis

Clinical Pharmacokinetics - United Kingdom
doi 10.1007/s40262-013-0049-6
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Effective Removal of Dabigatran by Idarucizumab or Hemodialysis: A Physiologically Based Pharmacokinetic Modeling Analysis

Clinical Pharmacokinetics
Pharmacology
2020English

Covariate Selection in Pharmacometric Analyses: A Review of Methods

British Journal of Clinical Pharmacology
Pharmacology
2014English

Intrinsic Dynamics and Pharmacometric Model Discrimination

1995English

Characterization of Thrombin-Bound Dabigatran Effects on Protease-Activated Receptor-1 Expression and Signaling in Vitro

Molecular Pharmacology
Molecular MedicinePharmacology
2015English

Dabigatran Inhibits Intravitreal Thrombin Activity

Acta Ophthalmologica
MedicineOphthalmology
2017English

Dabigatran-Induced Oesophagitis Dissecans Superficialis

Pathology
Forensic MedicinePathology
2020English

Dabigatran, Fears in Doctors’ Minds.

The Bangkok Medical Journal
2018English

Synthesis and Characterization Chitosan-Glutaraldehide Alginate Blends for Candidate Hemodialysis Membrane

Rasayan Journal of Chemistry
PharmacologyBiochemistryEnergyChemical EngineeringToxicologyChemistryPharmaceutics
2017English

Diffuse Alveolar Hemorrhage Associated With Dabigatran

Internal Medicine
Internal MedicineMedicine
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy